Cargando…

Application of Intravoxel Incoherent Motion Diffusion-Weighted Imaging in Predicting and Monitoring Early Efficacy of Anti-Angiogenic Therapy in the C6 Glioma Rat Model

OBJECTIVE: To investigate the feasibility of intravoxel incoherent motion (IVIM) diffusion-weighted imaging (DWI) in evaluating early effects of anti-angiogenic therapy in the C6 glioma rat model. METHODS: Twenty-six rats of the C6 glioma model were randomly divided into a treatment group (received...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Weishu, Xue, Yangyang, Qian, Yinfeng, Pan, Hongli, Xu, Man, Shen, Yujun, Li, Xiaohu, Yu, Yongqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831888/
https://www.ncbi.nlm.nih.gov/pubmed/35155219
http://dx.doi.org/10.3389/fonc.2021.842169
_version_ 1784648604393144320
author Hou, Weishu
Xue, Yangyang
Qian, Yinfeng
Pan, Hongli
Xu, Man
Shen, Yujun
Li, Xiaohu
Yu, Yongqiang
author_facet Hou, Weishu
Xue, Yangyang
Qian, Yinfeng
Pan, Hongli
Xu, Man
Shen, Yujun
Li, Xiaohu
Yu, Yongqiang
author_sort Hou, Weishu
collection PubMed
description OBJECTIVE: To investigate the feasibility of intravoxel incoherent motion (IVIM) diffusion-weighted imaging (DWI) in evaluating early effects of anti-angiogenic therapy in the C6 glioma rat model. METHODS: Twenty-six rats of the C6 glioma model were randomly divided into a treatment group (received bevacizumab) and a control group (physiological saline). IVIM-DWI was performed on days 0, 1, 3, 5, and 7 after anti-angiogenic therapy and tumor growth and IVIM-DWI parameters were dynamically observed. Hematoxylin and eosin, CD34 microvessel density (MVD), proliferation of cell nuclear antigen (PCNA), and Hif-α staining were performed on day 7. One-way ANOVA was used to compare intra-group differences and an independent-samples t-test was used to compare inter-group differences of MRI parameters. Correlations between IVIM-DWI parameters, tumor size, and pathological results were analyzed. RESULTS: The relative change in tumor volume (ΔVolume) in the two groups differed significantly on days 5 and 7 (p = 0.038 and p < 0.001). The perfusion-related parameters D*- and f-values decreased in the treatment group and demonstrated significant differences compared with the control group on days 3, 5, and 7 (p = 0.033, p < 0.001, and p < 0.001, respectively). The diffusion-related parameters ADC and D-values increased in the treatment group and were found to be significantly differently different from the control group on days 5 and 7 (both p < 0.001). The initial D-value showed a negative correlation with ΔVolume (γ = −0.744, p < 0.001), whereas the initial D*-value and relative change of D-value had a positive correlation with ΔVolume (γ = 0.718, p < 0.001 and γ = 0.800, p < 0.001, respectively). MVD was strongly positively correlated with D*-value (r = 0.886, p = 0.019), PCNA was negatively correlated with ADC- and D-values (r = −0.848, p = 0.033; and r = −0.928 p = 0.008, respectively), and Hif-1α was strongly negatively correlated with D*-value (r = −0.879, p = 0.010). CONCLUSION: IVIM-DWI was sensitive and accurate in predicting and monitoring the effects of early anti-angiogenesis therapy in a C6 glioma rat model.
format Online
Article
Text
id pubmed-8831888
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88318882022-02-12 Application of Intravoxel Incoherent Motion Diffusion-Weighted Imaging in Predicting and Monitoring Early Efficacy of Anti-Angiogenic Therapy in the C6 Glioma Rat Model Hou, Weishu Xue, Yangyang Qian, Yinfeng Pan, Hongli Xu, Man Shen, Yujun Li, Xiaohu Yu, Yongqiang Front Oncol Oncology OBJECTIVE: To investigate the feasibility of intravoxel incoherent motion (IVIM) diffusion-weighted imaging (DWI) in evaluating early effects of anti-angiogenic therapy in the C6 glioma rat model. METHODS: Twenty-six rats of the C6 glioma model were randomly divided into a treatment group (received bevacizumab) and a control group (physiological saline). IVIM-DWI was performed on days 0, 1, 3, 5, and 7 after anti-angiogenic therapy and tumor growth and IVIM-DWI parameters were dynamically observed. Hematoxylin and eosin, CD34 microvessel density (MVD), proliferation of cell nuclear antigen (PCNA), and Hif-α staining were performed on day 7. One-way ANOVA was used to compare intra-group differences and an independent-samples t-test was used to compare inter-group differences of MRI parameters. Correlations between IVIM-DWI parameters, tumor size, and pathological results were analyzed. RESULTS: The relative change in tumor volume (ΔVolume) in the two groups differed significantly on days 5 and 7 (p = 0.038 and p < 0.001). The perfusion-related parameters D*- and f-values decreased in the treatment group and demonstrated significant differences compared with the control group on days 3, 5, and 7 (p = 0.033, p < 0.001, and p < 0.001, respectively). The diffusion-related parameters ADC and D-values increased in the treatment group and were found to be significantly differently different from the control group on days 5 and 7 (both p < 0.001). The initial D-value showed a negative correlation with ΔVolume (γ = −0.744, p < 0.001), whereas the initial D*-value and relative change of D-value had a positive correlation with ΔVolume (γ = 0.718, p < 0.001 and γ = 0.800, p < 0.001, respectively). MVD was strongly positively correlated with D*-value (r = 0.886, p = 0.019), PCNA was negatively correlated with ADC- and D-values (r = −0.848, p = 0.033; and r = −0.928 p = 0.008, respectively), and Hif-1α was strongly negatively correlated with D*-value (r = −0.879, p = 0.010). CONCLUSION: IVIM-DWI was sensitive and accurate in predicting and monitoring the effects of early anti-angiogenesis therapy in a C6 glioma rat model. Frontiers Media S.A. 2022-01-28 /pmc/articles/PMC8831888/ /pubmed/35155219 http://dx.doi.org/10.3389/fonc.2021.842169 Text en Copyright © 2022 Hou, Xue, Qian, Pan, Xu, Shen, Li and Yu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Hou, Weishu
Xue, Yangyang
Qian, Yinfeng
Pan, Hongli
Xu, Man
Shen, Yujun
Li, Xiaohu
Yu, Yongqiang
Application of Intravoxel Incoherent Motion Diffusion-Weighted Imaging in Predicting and Monitoring Early Efficacy of Anti-Angiogenic Therapy in the C6 Glioma Rat Model
title Application of Intravoxel Incoherent Motion Diffusion-Weighted Imaging in Predicting and Monitoring Early Efficacy of Anti-Angiogenic Therapy in the C6 Glioma Rat Model
title_full Application of Intravoxel Incoherent Motion Diffusion-Weighted Imaging in Predicting and Monitoring Early Efficacy of Anti-Angiogenic Therapy in the C6 Glioma Rat Model
title_fullStr Application of Intravoxel Incoherent Motion Diffusion-Weighted Imaging in Predicting and Monitoring Early Efficacy of Anti-Angiogenic Therapy in the C6 Glioma Rat Model
title_full_unstemmed Application of Intravoxel Incoherent Motion Diffusion-Weighted Imaging in Predicting and Monitoring Early Efficacy of Anti-Angiogenic Therapy in the C6 Glioma Rat Model
title_short Application of Intravoxel Incoherent Motion Diffusion-Weighted Imaging in Predicting and Monitoring Early Efficacy of Anti-Angiogenic Therapy in the C6 Glioma Rat Model
title_sort application of intravoxel incoherent motion diffusion-weighted imaging in predicting and monitoring early efficacy of anti-angiogenic therapy in the c6 glioma rat model
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831888/
https://www.ncbi.nlm.nih.gov/pubmed/35155219
http://dx.doi.org/10.3389/fonc.2021.842169
work_keys_str_mv AT houweishu applicationofintravoxelincoherentmotiondiffusionweightedimaginginpredictingandmonitoringearlyefficacyofantiangiogenictherapyinthec6gliomaratmodel
AT xueyangyang applicationofintravoxelincoherentmotiondiffusionweightedimaginginpredictingandmonitoringearlyefficacyofantiangiogenictherapyinthec6gliomaratmodel
AT qianyinfeng applicationofintravoxelincoherentmotiondiffusionweightedimaginginpredictingandmonitoringearlyefficacyofantiangiogenictherapyinthec6gliomaratmodel
AT panhongli applicationofintravoxelincoherentmotiondiffusionweightedimaginginpredictingandmonitoringearlyefficacyofantiangiogenictherapyinthec6gliomaratmodel
AT xuman applicationofintravoxelincoherentmotiondiffusionweightedimaginginpredictingandmonitoringearlyefficacyofantiangiogenictherapyinthec6gliomaratmodel
AT shenyujun applicationofintravoxelincoherentmotiondiffusionweightedimaginginpredictingandmonitoringearlyefficacyofantiangiogenictherapyinthec6gliomaratmodel
AT lixiaohu applicationofintravoxelincoherentmotiondiffusionweightedimaginginpredictingandmonitoringearlyefficacyofantiangiogenictherapyinthec6gliomaratmodel
AT yuyongqiang applicationofintravoxelincoherentmotiondiffusionweightedimaginginpredictingandmonitoringearlyefficacyofantiangiogenictherapyinthec6gliomaratmodel